FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3151122701> ?p ?o ?g. }

• W3151122701 abstract "In the acute management of ST-elevation myocardial infarction (STEMI), glycoprotein IIb/IIIa inhibitors (GPIs) bolus not followed by intravenous infusion is potentially advantageous given their fast onset and offset of action, but clinical evidence in a contemporary setting is limited.We collected data from consecutive STEMI patients admitted to the cardiac catheterization laboratory of the IRCCS A. Gemelli University Polyclinic Foundation from October 2017 to September 2019.Out of 423 consecutive STEMI patients, 297 met the inclusion and exclusion criteria and were included in the study. Of them, 107/297 (36%) received an intracoronary GPI bolus-only during primary percutaneous coronary intervention (PPCI) not followed by intravenous infusion and 190/297 (64%) received standard antithrombotic therapy. Of the 107 GPI-treated, 22/107 (21%) had P2Y<inf>12</inf> inhibitor pretreatment (adjunctive strategy) and 85/107 (79%) did not (bridging strategy). During hospital staying, there was no difference in the primary safety endpoint of TIMI major+minor bleeding (P=0.283), TIMI major (P=0.267) or TIMI minor (P=0.685) bleeding between groups. No stroke event occurred in the GPI group. Despite patients receiving GPI having a significantly higher intraprocedural ischemic burden, no significant differences were found in the efficacy outcomes between groups. Consistent findings were observed for patients receiving GPIs bolus before (bridging strategy) or after (adjunctive strategy) P2Y<inf>12</inf> inhibitors, compared to those receiving standard therapy. Multivariate logistic regression analyses did not find any independent predictors significantly associated to the primary and secondary composite endpoints.In a contemporary real-world population of STEMI patients undergoing PPCI, the use of intracoronary GPIs bolus-only in selected patients at high ischemic risk is safe and could represent a useful antithrombotic strategy both in those pretreated and in those naïve to P2Y<inf>12</inf> inhibitors." @default.
• W3151122701 created "2021-04-13" @default.
• W3151122701 creator A5003293531 @default.
• W3151122701 creator A5011167352 @default.
• W3151122701 creator A5024728880 @default.
• W3151122701 creator A5028654611 @default.
• W3151122701 creator A5029130187 @default.
• W3151122701 creator A5029687135 @default.
• W3151122701 creator A5031325008 @default.
• W3151122701 creator A5031505042 @default.
• W3151122701 creator A5033442682 @default.
• W3151122701 creator A5053770843 @default.
• W3151122701 creator A5058994869 @default.
• W3151122701 creator A5065403268 @default.
• W3151122701 creator A5065473932 @default.
• W3151122701 creator A5065904940 @default.
• W3151122701 creator A5079881065 @default.
• W3151122701 creator A5080268131 @default.
• W3151122701 creator A5083754879 @default.
• W3151122701 creator A5084836497 @default.
• W3151122701 creator A5091851552 @default.
• W3151122701 date "2023-01-01" @default.
• W3151122701 modified "2023-09-30" @default.
• W3151122701 title "Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of ST-elevation myocardial infarction" @default.
• W3151122701 cites W1514184553 @default.
• W3151122701 cites W1538704194 @default.
• W3151122701 cites W1984006644 @default.
• W3151122701 cites W1987751736 @default.
• W3151122701 cites W2045786500 @default.
• W3151122701 cites W2046359098 @default.
• W3151122701 cites W2088306306 @default.
• W3151122701 cites W2097646648 @default.
• W3151122701 cites W2099058771 @default.
• W3151122701 cites W2114995492 @default.
• W3151122701 cites W2123112974 @default.
• W3151122701 cites W2133091573 @default.
• W3151122701 cites W2139834809 @default.
• W3151122701 cites W2140501627 @default.
• W3151122701 cites W2144206796 @default.
• W3151122701 cites W2146755388 @default.
• W3151122701 cites W2150655309 @default.
• W3151122701 cites W2169387542 @default.
• W3151122701 cites W2189063229 @default.
• W3151122701 cites W2520637476 @default.
• W3151122701 cites W2532584865 @default.
• W3151122701 cites W2546429006 @default.
• W3151122701 cites W2590563478 @default.
• W3151122701 cites W2754054868 @default.
• W3151122701 cites W2808265769 @default.
• W3151122701 cites W2898391404 @default.
• W3151122701 cites W2911192910 @default.
• W3151122701 cites W2916912835 @default.
• W3151122701 cites W2965476153 @default.
• W3151122701 cites W2973068166 @default.
• W3151122701 cites W3022148767 @default.
• W3151122701 cites W3037005132 @default.
• W3151122701 doi "https://doi.org/10.23736/s2724-5683.21.05669-6" @default.
• W3151122701 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33823577" @default.
• W3151122701 hasPublicationYear "2023" @default.
• W3151122701 type Work @default.
• W3151122701 sameAs 3151122701 @default.
• W3151122701 citedByCount "3" @default.
• W3151122701 countsByYear W31511227012022 @default.
• W3151122701 countsByYear W31511227012023 @default.
• W3151122701 crossrefType "journal-article" @default.
• W3151122701 hasAuthorship W3151122701A5003293531 @default.
• W3151122701 hasAuthorship W3151122701A5011167352 @default.
• W3151122701 hasAuthorship W3151122701A5024728880 @default.
• W3151122701 hasAuthorship W3151122701A5028654611 @default.
• W3151122701 hasAuthorship W3151122701A5029130187 @default.
• W3151122701 hasAuthorship W3151122701A5029687135 @default.
• W3151122701 hasAuthorship W3151122701A5031325008 @default.
• W3151122701 hasAuthorship W3151122701A5031505042 @default.
• W3151122701 hasAuthorship W3151122701A5033442682 @default.
• W3151122701 hasAuthorship W3151122701A5053770843 @default.
• W3151122701 hasAuthorship W3151122701A5058994869 @default.
• W3151122701 hasAuthorship W3151122701A5065403268 @default.
• W3151122701 hasAuthorship W3151122701A5065473932 @default.
• W3151122701 hasAuthorship W3151122701A5065904940 @default.
• W3151122701 hasAuthorship W3151122701A5079881065 @default.
• W3151122701 hasAuthorship W3151122701A5080268131 @default.
• W3151122701 hasAuthorship W3151122701A5083754879 @default.
• W3151122701 hasAuthorship W3151122701A5084836497 @default.
• W3151122701 hasAuthorship W3151122701A5091851552 @default.
• W3151122701 hasConcept C126322002 @default.
• W3151122701 hasConcept C164705383 @default.
• W3151122701 hasConcept C168563851 @default.
• W3151122701 hasConcept C203092338 @default.
• W3151122701 hasConcept C2777698277 @default.
• W3151122701 hasConcept C2777849778 @default.
• W3151122701 hasConcept C2777995511 @default.
• W3151122701 hasConcept C2780400711 @default.
• W3151122701 hasConcept C2780739214 @default.
• W3151122701 hasConcept C2781056559 @default.
• W3151122701 hasConcept C43376680 @default.
• W3151122701 hasConcept C500558357 @default.
• W3151122701 hasConcept C71924100 @default.
• W3151122701 hasConceptScore W3151122701C126322002 @default.
• W3151122701 hasConceptScore W3151122701C164705383 @default.
• W3151122701 hasConceptScore W3151122701C168563851 @default.

• next